Newest by Mastelli: What This Polynucleotide Gel Does
You have come across the name Newest in recommendations and wonder what is being offered: another “beauty injection,” a true contour filler or a skin-quality treatment? Newest® by Italy's Mastelli is a specific intradermal injectable gel containing PN HPT® polynucleotides, linear hyaluronic acid and mannitol. Its manufacturer describes use for dehydrated and mature skin on the face, neck and décolletage. The intended goal is improved hydration, firmness and skin appearance, not mechanically lifting tissues that have descended. “Rejuvenation with no visible traces” is too strong a promise: responses vary, evidence is mixed and injection marks may be noticeable.
Your first question should not be “how many millilitres do I need?” but “which exact Newest, for which area, supported by which documents and studies?” Newest and Newest One sound alike but are different formulations. An international product listing alone does not prove that a particular batch is registered or available in Armenia.
What exactly is in the syringe, and why does the formulation matter?
According to Mastelli, standard Newest comes as a 2 mL prefilled syringe with 20 mg of highly purified PN HPT® polynucleotides and 20 mg of linear hyaluronic acid per syringe—10 mg/mL of each. Mannitol, water and buffering salts are also listed. These ingredients and quantities can be verified; the term “bioregeneration” describes a proposed action, not a guaranteed outcome.
Polynucleotides are fragments of nucleic-acid chains. Researchers discuss their effects on skin-cell processes, inflammatory signalling and tissue repair, but laboratory findings cannot be converted directly into a prediction about your wrinkles. Hyaluronic acid binds water and contributes to tissue hydration. The acid here is described as linear, rather than a dense cross-linked contour filler intended to create pronounced cheek or chin volume. Mannitol is an additional ingredient; its inclusion does not prove a separate lifting benefit.
| Product | What the manufacturer confirms | Why they are not interchangeable |
|---|---|---|
| Newest® | 2 mL syringe; PN HPT® 20 mg and hyaluronic acid 20 mg; face, neck and décolletage; dehydrated and mature skin. | The PN + HA combination was specifically used in the acne-scar studies discussed below. |
| Newest One® | 4 mL single-use vials; PN HPT® 4 mg and hyaluronic acid 4 mg per vial; larger body areas, such as arms, abdomen and thighs. | Different concentration, packaging and treatment sites: Newest regimens and findings cannot simply be applied to Newest One. |
| Plinest® | A separate Mastelli polynucleotide range without the same PN + HA combination as Newest. | Studies of Plinest are not studies of Newest itself; a shared ingredient does not make products identical. |
If someone says all polynucleotides are the same, ask to see the box, the complete product name and the instructions for that exact formulation. An overview of polynucleotides and PDRN explains the broader category; here the decision concerns Newest's verifiable specifications. Neither PolyPhil nor Filart should be assessed using instructions for a different product.
What could Newest change—and what will it not fix?
A reasonable aim is a modest improvement in how dehydrated skin looks and feels: it may appear less dry, smoother and firmer. Mastelli also mentions treatment of fibrous areas and indented scars. But post-acne pits, deep wrinkles, pigmentation, marked jowls and excess skin are different problems. Polynucleotide gel does not remove surplus skin, move descended facial fat compartments or replace the diagnosis of ongoing inflammation or scarring.
If acne scars bother you, a clinician first determines their type. Narrow deep ice-pick scars, broad rolling depressions, shallower scars and scars tethered by fibrous bands may need different treatment. “Newest removes scars” erases this distinction. Published observations involved adults with moderate-to-severe atrophic acne scars, with individually selected injection techniques. They cannot predict changes to a single eye-area wrinkle or the firmness of your neck.
Under the eyes, fine dehydration lines are easily confused with protruding fat pads, puffiness and anatomical shadows. Each has different risks, appropriate injection depths and product choices. Although the manufacturer lists the face, neck and décolletage for standard Newest, that does not automatically authorize use in the tear trough or thin eyelid skin. Ask the clinician to verify the permitted area in the current instructions for the actual batch.
What do clinical studies show—and what remains unknown?
A systematic review of aesthetic PN research published in 2025 included nine studies involving 219 people. A 2026 review of randomized PN and PDRN trials included seven studies and 183 people across different dermatologic uses. Both described small samples, differing formulations and methods, and limits on conclusions, especially about long-term safety. Neither supports a reliable Newest success percentage for every woman. Some research has manufacturer funding or involvement; read the methods and conflicts of interest rather than accepting or rejecting findings solely on that basis.
For Newest itself, an open-label prospective multicentre study involved 62 people with atrophic post-acne scars. It used PN HPT® 10 mg/mL plus hyaluronic acid 10 mg/mL in four sessions two weeks apart, followed by assessment. Another prospective hospital-outpatient study followed 30 participants to completion, scoring scars at 3 and 6 months; not everyone improved. These are clinical observations of a particular combination for a specific problem, not large independent blinded trials covering every proposed aesthetic indication.
Separate three levels of claim: the manufacturer's stated intended use, a finding in a studied group and an individual forecast for you. Product certification, even when valid, does not demonstrate that every marketing claim was tested. Research describes Newest as a CE-marked Class III medical device in a European regulatory context. Current certificate validity, batch compliance and lawful use in Armenia all require separate documentation. Among the sources reviewed by 22 October 2026, there was no confirmation of FDA clearance or approval for this precise formulation and these aesthetic uses; European CE marking is not US authorization.
Useful questions are: did the study assess this Newest formulation, or PN treatments in general? Was there a comparison group and independent evaluation? Were outcomes assessed after months rather than immediately after injection and swelling? Was it compared with basic skincare or another therapy? “Good comparative evidence is not yet sufficient” is a more valuable answer than a claim that your skin will become a fixed number of years younger.
Who might consider it, and who should look elsewhere?
| What you notice | How to think about Newest | What to ask before deciding |
|---|---|---|
| Surface dryness and tightness | First examine skincare, tolerance of active products, sunscreen use and your skin barrier; injections may not be necessary. | Could eczema, irritation or a medicine be causing dryness? |
| Fine lines and reduced elasticity with a fairly stable facial contour | A modest skin-quality improvement may be discussed; it is not the same as tightening the face. | How will improvement be measured without lighting differences or swelling? |
| Post-acne scars | Potentially one element of a combined plan after assessing scar type and depth. | Is subcision, laser treatment or another technique needed, and why? |
| Marked sagging, deep folds or excess skin | Do not expect a surgical lifting result. | Compare conservative options with the possibility of a plastic surgery consultation. |
| Active inflammation, herpes or infection at injection sites | Postpone cosmetic injections until assessment and treatment. | When could the procedure safely be reconsidered? |
Before an injection, a clinician should ask about pregnancy or breastfeeding, severe allergic reactions, possible sensitivity to fish-derived ingredients, clotting problems, anticoagulants, immune conditions, keloid history and previous procedures in the area. This is not a universal list of absolute contraindications: the specific formulation and official instructions govern the decision. With inadequate safety evidence for elective cosmetic use during pregnancy and lactation, postponement is sensible. Do not discontinue prescribed medicine on your own to receive injections.
What is a session like, and what might you see afterwards?
The process usually begins with a skin examination, consistent-lighting photographs, discussion of goals and a medical history. The clinician checks intact packaging and expiry, discusses anaesthesia and marks areas for intradermal placement. Mastelli describes microdroplet or linear needle techniques for Newest; the qualified clinician chooses the specific technique and dose. You may feel brief punctures, stinging or pressure depending on the area and your sensitivity. Completely pain-free treatment should not be promised.
Mastelli describes a 3–4-session protocol at intervals of 14–21 days. That is a product protocol, not a compulsory course for every patient. The clinician may modify or decline the plan for medical reasons. Studies on scars have used their own schedules, which should not automatically be transferred to the neck, eyelids or uncomplicated dry skin. Do not commit to paying for a long series before the criteria for continuing are explained.
On injection day, small raised bumps at the needle sites, tiny marks, redness and tenderness are possible. Swelling and bruising may remain visible over the following days. Their social visibility varies with injection depth, site, bruising tendency and number of punctures. Being medically able to resume everyday activity does not mean colleagues or a phone camera will see nothing. No one can guarantee the exact day that papules or bruises will disappear.
For planning, distinguish three moments: on the treatment day, injection points may be visible even without bruising; several days later, some swelling or bruising may remain; even by the end of the first week, a clear appearance cannot be guaranteed, particularly with sensitive skin. These are possibilities, not obligatory stages or a personal healing forecast. If symptoms worsen, become painful or depart from your clinician’s instructions, seek an assessment rather than waiting for an arbitrary “day seven.”
If you have a wedding, photoshoot, important meeting or flight ahead, do not schedule your first-ever injection immediately before it. Discuss when makeup, exercise, saunas, strong sun exposure and acids or retinoids can be resumed; advice depends on your skin and local clinical protocol. Do not uncritically borrow aftercare instructions for dense contour fillers or laser resurfacing.
Which symptoms are expected, and which need attention?
Short-lived tenderness, redness, bumps and bruises are possible. Infection, persistent nodules, inflammation, allergic reaction or dissatisfaction may also occur. Small studies and limited follow-up cannot reliably quantify rare adverse events with this formulation or rule them out. Any facial injection needs sterile conditions, an appropriately trained medical practitioner and a plan for complications.
Increasing pain, rapidly worsening swelling, marked hot redness, discharge, fever or unexpected tissue discoloration merit urgent medical assessment, not massage at home. Vision changes, sudden severe pain or new neurological symptoms require emergency help. These are general facial-injection safety instructions, not claims that such outcomes are typical of Newest.
How can you check the offer without turning the appointment into an interrogation?
Ask for the complete trade name, manufacturer, volume and concentration, intact original pack, lot number, expiry date and instructions for the local market. Ask whether importation and clinical use are lawful where you are being treated. The international Mastelli site cannot tell you whether any clinic in Yerevan has legally supplied original stock. A social-media picture of a box alone is not verification.
Then explain which visible sign you hope to improve, over what timeframe and by what measure. Request comparable before-and-after pictures with matching angles and lighting, including images after swelling has settled. Beyond the portfolio's best outcomes, consider a modest change, no perceptible change or stopping the course. Ask for the complete planned cost, including assessment and management of side effects, without relying on invented average prices.
If injections themselves do not appeal to you, basic skincare, photoprotection, reducing irritating actives and, for scars, a dermatologist's discussion of established treatments are all reasonable starting points. Keeping your familiar appearance and declining treatment are valid decisions. Newest is one specific possible skin-quality tool, not a measure of how well you look after yourself.
Further questions
Can I combine Newest with retinoids at home?
The timing of active skincare around a procedure depends on your reaction and skin barrier. Discuss the exact products and when to restart with your treating clinician; no interval suits everyone.
Is Newest suitable if my skin is prone to rosacea?
First determine whether inflammation and irritation are currently active. Injections may worsen redness; a dermatologist, rather than marketing material, should decide if and when treatment is suitable.
Can I verify authenticity from the name Newest alone?
No. You need the complete product variant, official supply and labelling documents, lot number, expiry and confirmation from an authorized distributor. Similar-looking packaging in a photograph is not independent verification.